Dr. Proctor is a Licensed Clinical Psychologist who specializes in the evaluation of behavioral health care treatment systems with a particular focus on addictions treatment outcomes. He collaborates with national and local agencies to improve their treatment systems through research, surveillance efforts, technical assistance, training, and program evaluation. He has an extensive publication record including numerous peer-reviewed journal articles in these areas, and frequently presents the findings from his work at scientific meetings. He is Principal Investigator on a Small Business Innovation Research (SBIR) grant from the National Institute on Drug Abuse (NIDA), and is Co-Investigator on several federally-funded research grants. He is a Fellow of Yale University's NIDA-funded 'Innovation to Impact' entrepreneurship training program for addictions researchers, and has received several awards for his work including a 'Rising Star Award' from the Association for Psychological Science, 'New Investigator Award' from the American Society of Clinical Psychopharmacology, and 'NIDA Young Investigator Travel Award' from the American Society of Addiction Medicine. He has worked with a number of agencies ranging from individual treatment centers to national behavioral health care organizations and government agencies, including:
Ph.D., Clinical Psychology
Department of Psychology
Baton Rouge, Louisiana
Innovation to Impact
New Haven, Connecticut
Addictive Disorders Treatment Program
Veterans Health Administration
Predoctoral Clinical Residency
Federal Bureau of Prisons
Los Angeles, California
M.A., Clinical Psychology
Cullowhee, North Carolina
B.S., Psychology (with Honors)
Boone, North Carolina
Steven L. Proctor, Ph.D.
State of Florida (License No: PY10022)
President, Evince Clinical Assessments
Dr. Hoffmann is a nationally and internationally recognized expert in the evaluation of addictions and behavioral health treatment programs and in the clinical assessment of addictive and mental health disorders. He is a professional clinical psychologist with more than 30 years of experience in the development of practical evaluation and clinical assessment instruments for use in employee assistance programs, addictions treatment facilities, hospitals, and mental health settings. His assessment instruments are currently used throughout the United States, as well as Canada, Sweden, Norway, and the United Kingdom. Dr. Hoffmann's publication record includes more than 200 journal articles and book chapters.
Dr. Herschman is a national behavioral health care expert with over 45 years of experience. Areas of specialization include consultation to providers and investors. He is a clinical psychologist and invited speaker on clinical excellence and addiction treatment with keynote and panel presentations at several national conferences. Dr. Herschman has been a featured expert for The Today Show, as well as magazines such as Time, Renew, Addiction Professional, and Behavioral Healthcare. Previous positions include serving as Chief Clinical Officer for CRC Health Group, and Chief Executive Officer of Behavioral Health Concepts, a national mental health management company.
Dr. Rigg is a health services researcher with over 15 years of experience studying substance use disorders. He specializes in qualitative/mixed-methods research and has been involved in numerous studies using focus groups, in-depth interviewing, and photovoice. His research on opioid addiction has helped guide clinicians, law enforcement, regulatory agencies, and industry to develop policy initiatives and recommendations for treatment best practices. His work has been cited in court cases, congressional hearings, policy briefs, as well as covered in the media. Dr. Rigg has published over 40 peer-reviewed journal articles and has worked on federally-funded research projects by the Centers for Disease Control & Prevention (CDC) and the National Institute on Drug Abuse (NIDA). He also sits on the editorial boards of several scientific journals including Psychology of Addictive Behaviors, Substance Use & Misuse, and Qualitative Social Work.
Dr. Kopak specializes in the treatment and assessment of substance use disorders in criminal justice settings and the use of advanced statistical modeling techniques. He has provided consultation to various criminal justice agencies in the US and UK. He is proficient in the use of a number of statistical software packages, including STATA, SPSS, and MPlus, and has received extensive training in advanced quantitative methods. He is skilled in a variety of statistical techniques, such as hierarchical linear modeling (HLM), structural equation modeling (SEM), factor analyses, latent class analysis, propensity score analyses, multiple/logistic regression, and virtually all types of predictive latent growth models. He also holds a faculty appointment at the rank of associate professor of criminology, and has authored over 60 journal articles and book chapters.
President, Shulman Solutions
Gerald Shulman is a licensed clinical psychologist, Master Addiction Counselor, Fellow of the American College of Addiction Treatment Administrators, and is board-certified by the American Academy of Psychologists Treating Addiction. He has over 50 years of experience providing addictions treatment and clinically or administratively supervising the delivery of care. Areas of specialization include older adults with substance use disorders and implementation and use of the ASAM Criteria. He is the author of over 80 articles and clinical instruments.
While Dr. Proctor looks forward to meeting all potential clients' needs, he has identified the following Associates based on their expertise and longstanding history of providing high quality training and consultation services in their respective areas of specialization.
Far too often I see various treatment program marketing strategies use words like 'effective,' 'best-in-class,' proven,' 'evidence-based,' etc. to describe their clinical services in the absence of objective empirical data to support such claims. Individuals suffering from addiction and their loved ones deserve better than that. Statements such as these should be reserved for treatment programs with an established, well-designed outcomes monitoring system or those with demonstrated evidence of effectiveness from a rigorous independent evaluation.
Although I am fortunate for my varied clinical and research experiences and roles, I have found my work as a trusted advisor and independent consultant to be the most rewarding due to its applied focus and its potential to have a meaningful impact on real-world practice and policy."
"I am committed to improving the effectiveness of addictions treatment services.
The diversity of my clinical and research experiences to date has furnished me with a firm knowledge of clinical treatment issues and research methodology––which has proven useful in my role as a consultant as I provide advice and guidance to treatment agencies to get to a place of measurement-based and outcomes-informed care.
-Division 50 - Society of Addiction Psychology
-Division 41 - American Psychology-Law Society
-Division 18 - Psychologists in Public Service
-Division 12 - Society of Clinical Psychology
-Addictive Behaviors Special Interest Group
-Criminal Justice Special Interest Group